Close Menu

ChanTest

NEW YORK (GenomeWeb News) – BioFocus today said that it has signed an agreement to offer ChanTest's cell line library and Channel Panel profiling services.

NEW YORK (GenomeWeb News) – Roched has entered into an agreement with ChanTest to evaluate the safety of potential drug compounds.

ChanTest will develop non-clinical assays, databases, and computational models for assessing the risk of serious cardiac events associated with drug-induced QT prolongation.

Molecular Devices will also sell ChanTest's cell optimization services to Molecular Devices' customers worldwide using its PatchXpress 7000A, IonWorks Quattro, IonWorks Barracuda, and FLIPR Tetra systems.

News Scan: Feb 27, 2009

Premium

DiscoveryBioMed, ArtusLabs, Heptares Therapeutics, Gentronix, GlaxoSmithKline, BioFocus DPI, Eli Lilly, Millipore, Epitome, ChanTest, Applied Cell Sciences, BioTime, Embryome Sciences, Reproductive Genetics Institute of Chicago, Arizona State University Biodesign Institute, VisionGate

The acquisition will add ACS' GPCR capabilities to ChanTest's ion channel testing services and validated cell lines.

Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.

The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.

Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.

This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.